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Characterization of the Streptomyces coelicolor Glycoproteome
Reveals Glycoproteins Important for Cell Wall Biogenesis
Tessa Keenan,a Adam Dowle,b Rachel Bates,b Margaret C. M. Smitha
aDepartment of Biology, University of York, York, United Kingdom
bBioscience Technology Facility, University of York, York, United Kingdom
ABSTRACT The physiological role of protein O-glycosylation in prokaryotes is
poorly understood due to our limited knowledge of the extent of their glycopro-
teomes. In Actinobacteria, defects in protein O-mannosyl transferase (Pmt)-mediated
protein O-glycosylation have been shown to signiﬁcantly retard growth (Mycobacte-
rium tuberculosis and Corynebacterium glutamicum) or result in increased sensitivities
to cell wall-targeting antibiotics (Streptomyces coelicolor), suggesting that protein
O-glycosylation has an important role in cell physiology. Only a single glycoprotein
(SCO4142, or PstS) has been identiﬁed to date in S. coelicolor. Combining biochemi-
cal and mass spectrometry-based approaches, we have isolated and characterized
the membrane glycoproteome in S. coelicolor. A total of ninety-ﬁve high-conﬁdence
glycopeptides were identiﬁed which mapped to thirty-seven new S. coelicolor glyco-
proteins and a deeper understanding of glycosylation sites in PstS. Glycosylation
sites were found to be modiﬁed with up to three hexose residues, consistent with
what has been observed previously in other Actinobacteria. S. coelicolor glycopro-
teins have diverse roles and functions, including solute binding, polysaccharide hy-
drolases, ABC transporters, and cell wall biosynthesis, the latter being of potential
relevance to the antibiotic-sensitive phenotype of pmt mutants. Null mutants in
genes encoding a putative D-Ala-D-Ala carboxypeptidase (SCO4847) and an L,D-
transpeptidase (SCO4934) were hypersensitive to cell wall-targeting antibiotics. Addi-
tionally, the sco4847 mutants displayed an increased susceptibility to lysozyme treat-
ment. These ﬁndings strongly suggest that both glycoproteins are required for
maintaining cell wall integrity and that glycosylation could be affecting enzyme
function.
IMPORTANCE In prokaryotes, the role of protein glycosylation is poorly understood
due to our limited understanding of their glycoproteomes. In some Actinobacteria,
defects in protein O-glycosylation have been shown to retard growth and result in
hypersensitivity to cell wall-targeting antibiotics, suggesting that this modiﬁcation is
important for maintaining cell wall structure. Here, we have characterized the glyco-
proteome in Streptomyces coelicolor and shown that glycoproteins have diverse
roles, including those related to solute binding, ABC transporters, and cell wall bio-
synthesis. We have generated mutants encoding two putative cell wall-active glyco-
proteins and shown them to be hypersensitive to cell wall-targeting antibiotics.
These ﬁndings strongly suggest that both glycoproteins are required for maintaining
cell wall integrity and that glycosylation affects enzyme function.
KEYWORDS Actinobacteria, antibiotic resistance, cell wall biogenesis, glycopeptides,
mass spectrometry, protein O-glycosylation, protein O-mannosyltransferase
Protein modiﬁcation by glycosylation is a process that occurs in all domains of life(1, 2). Glycan moieties, which can be extremely diverse in structure and composi-
tion, are most commonly attached to either asparagine (N-glycosylation) or to serine/
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threonine (O-glycosylation) in the peptide chain. The presence of the glycan changes
the physicochemical properties of the protein and has been shown to have effects on
cellular localization, ligand binding, and stability (1). The enzymes mediating N- and
O-glycosylation are conserved between kingdoms, but studies on protein glycosylation
in prokaryotes lags behind that of eukaryotes. Consequently, with few exceptions (3–5),
the extent and functions of the glycoproteome in most prokaryotes are unclear.
Recent reports have described the phenotypes of bacteria lacking a protein-O-
mannosyl transferase (Pmt), and they are either strongly retarded in growth (Mycobac-
terium tuberculosis and Corynebacterium glutamicum) or have increased sensitivities to
several antibiotics that target the cell wall, including vancomycin and -lactams
(Streptomyces coelicolor) (6–8). These three bacterial species are all within the Actino-
bacteria, where the occurrence of Pmt is prevalent. In the case of Streptomyces, the pmt
mutants have also become resistant to infection by the phage C31, implying that the
glycans perform a role in ligand recognition (9). The O-glycoproteome from Mycobac-
terium tuberculosis has been extensively explored; in particular, the culture ﬁltrate
consists of more than forty glycoproteins, including potential cell wall-active glycopro-
teins, such as a putative glycosyl hydrolase (Rv1096) and the -lactamase BlaC
(Rv2068c) (10–14). In contrast, only a single glycoprotein (SCO4142; PstS) has been
identiﬁed to date in S. coelicolor (15). Given that the Pmt-mediated O-glycosylation
system is a general glycosylation system in other bacteria and fungi, we hypothesize
the presence of a glycoproteome in S. coelicolor and that one of its roles is in cell wall
biogenesis.
Pmt is a predicted integral membrane protein, and in M. tuberculosis it has been
shown to mannosylate unfolded proteins as they are secreted through the Sec system
(16). The sugar donor for Pmt is polyprenol phosphate mannose (PPM), which is made
intracytoplasmically via the transfer of mannose from GDP-mannose to polyprenol
phosphate by polyprenol phosphate mannose synthase (Ppm1) (15, 17). PPM is then
thought to be ﬂipped in the membrane so that the mannose moiety can be presented
to Pmt for transfer to the target proteins. S. coelicolor ppm1 mutants, and mutants
(manB and manC) with depleted enzymes that supply GDP-mannose to Ppm1, all have
phenotypes that resemble that of the pmtmutants but display more extreme antibiotic
sensitivities (6, 18).
The phenotypes of the pmt mutants imply that glycosylation has an important role
in cell physiology. The increased sensitivity of the S. coelicolor pmt mutants to the
antibiotics vancomycin and some -lactams suggests that glycosylation affects the
function of enzymes in cell wall biogenesis, possibly in peptidoglycan cross-linking.
Here, we investigate the Streptomyces glycoproteome, focusing on the membrane and
membrane-associated proteins with a view to elucidating the mechanism that under-
pins the antibiotic sensitivity. Using enrichment of the glycoproteome by lectin afﬁnity
chromatography followed by mass spectrometry, a total of ninety-ﬁve high-conﬁdence
glycopeptides were characterized from thirty-eight glycoproteins. S. coelicolor mutants
were constructed in genes encoding glycoproteins that could be involved in pepti-
doglycan biosynthesis and were found to have an antibiotic-sensitive phenotype. These
data indicate that protein glycosylation has a role in the functions of multiple periplas-
mic proteins.
RESULTS AND DISCUSSION
Enrichment and detection of a glycoproteome in S. coelicolor. To investigate the
glycoproteome in S. coelicolor, membrane protein fractions were isolated from the S.
coelicolor parent strain J1929 and the glycosylation-deﬁcient strains DT1025 (pmt
mutant) and DT3017 (ppm1mutant). The strains were cultivated in deﬁned, phosphate-
limited (F134) liquid medium, as expression of the previously characterized S. coelicolor
glycoprotein SCO4142 (PstS) was known to be induced on phosphate depletion (15, 19,
20). The proteins were separated by SDS-PAGE, blotted onto polyvinylidene diﬂuoride
(PVDF) membrane, and probed with concanavalin A (ConA) conjugated to horseradish
peroxidase (ConA-HRP) (see Fig. S1 in the supplemental material). Several ConA-
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reactive bands were observed in the J1929 membrane protein fraction within the 100-
to 40-kDa molecular weight range that were absent from the protein O-mannosyl
transferase- and polyprenol phosphate mannose synthase-deﬁcient strains DT1025
(pmt mutant) and DT3017 (ppm1 mutant) (Fig. S1B). The ConA reactivity was lost in the
presence of methyl -D-glucopyranoside, a competitive inhibitor of mannose and
glucose binding. These results demonstrate the presence of a glycoproteome in S.
coelicolor that requires the activities of Pmt and Ppm1.
To facilitate the characterization of the glycoproteome, lectin afﬁnity chromatogra-
phy was used to enrich for the S. coelicolor membrane glycoproteins. In order to
maximize the number of glycoproteins isolated and to account for any growth stage-
speciﬁc changes to the glycoproteome, glycoproteins were enriched from J1929 mem-
brane protein fractions isolated after 20, 35, 43, and 60 h of growth (Fig. S2). The total,
unbound, and enriched protein fractions were separated by SDS-PAGE, blotted onto a
PVDF membrane, and probed with ConA-HRP (Fig. 1). Over the four time points,
changes were observed in the abundance and numbers of proteins enriched after lectin
afﬁnity chromatography, as shown by Coomassie staining (Fig. 1, lanes 4, 7, 10, and 14),
suggesting that there are growth stage-speciﬁc changes to the membrane glycopro-
teome in S. coelicolor. The ConA reactivity proﬁles of the enriched fractions, which also
changed throughout the time course, are consistent with this observation (Fig. 1, lanes
17, 20, 23, and 26). The greatest number of strongly ConA-reactive bands were
observed in membrane protein fractions enriched after 35 and 43 h of growth, sug-
gesting that these fractions yield the most glycoproteins. The unbound fractions from
the ConA columns also yielded some cross-reactivity with ConA-HRP but mostly to
proteins that were abundant in the Coomassie-stained gels, suggesting nonspeciﬁc
ConA reactivity. Taken together, these results show that glycoproteins are expressed
throughout the S. coelicolor growth cycle and that the glycoproteome varies according
to the growth stage.
S. coelicolor glycoproteome characterization using mass spectrometry. In order
to identify the S. coelicolor glycoproteins isolated from the membrane proteome after
lectin afﬁnity chromatography (Fig. 1) and characterize the sites of modiﬁcation, liquid
chromatography (LC) coupled to tandem mass spectrometry (MS/MS) was carried out.
Since the previously characterized S. coelicolor glycoprotein PstS was shown to be
modiﬁed with a trihexose (15) and numerous glycoproteins with short mannose
modiﬁcations have been previously described in the closely related M. tuberculosis (10,
13, 21), we focused on short hexose modiﬁcations in our analyses. To enable a
comprehensive analysis of the S. coelicolor glycoproteome, several different peptide
fragmentation techniques were employed to facilitate both glycopeptide characteriza-
tion and glycosylation site assignment.
The fractions enriched in S. coelicolor glycoproteins after 20, 35, 43, and 60 h of
growth were each subjected to in-gel tryptic digestion after SDS-PAGE and analyzed by
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FIG 1 Glycoprotein enrichment time course by ConA afﬁnity chromatography. Total membrane (T), unbound membrane
(UB), and eluted (E) protein fractions were separated by SDS-PAGE and stained with protein stain (lanes 1 to 14) or probed
with ConA-HRP after Western blotting (lanes 15 to 26).
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liquid chromatography coupled to electrospray ionization collision-induced dissocia-
tion tandem mass spectrometry (LC-ESI-CID-MS/MS). A total of 24 different S. coelicolor
glycopeptides were identiﬁed over the four time points (Data Set S1), mapping to
ﬁfteen new S. coelicolor glycoproteins. The spectra of the glycopeptides obtained by
CID fragmentation were dominated by product ions formed due to the preferential
cleavage of glycosidic bonds. In these cases, the glycopeptide was identiﬁed when the
mass difference between the peptide backbone identiﬁed from the MS/MS spectra and
the precursor ion was equivalent to a hexose (162 Da) or multiples thereof. For
example, the glycopeptide N- SATAASPSAEASGEAGGTGK-C, belonging to SCO4847,
was shown to be modiﬁed with nine hexose residues (Fig. 2A). The triply charged
precursor ion atm/z 1,055.76 is consistent with a glycopeptide mass of 3,164.28 Da. The
predicted mass of unmodiﬁed N-SATAASPSAEASGEAGGTGK-C is 1,705.77 Da, which is a
difference of 9 hexose residues (1,458.47 Da) from the mass of the glycosylated peptide.
The spectrum is dominated by the y-ion series that validate the sequence of the
peptide backbone. While two ions were observed with the glycan intact (y14  2Hex
and MR  9Hex), these were not enough to assign the glycosylation sites in the
glycopeptide. Since the unambiguous assignment of the glycosylated amino acid
residue relies on the observation of peptide product ions containing at least one
hexose residue, in many cases it was not possible to map the glycosylation sites in the
glycopeptides identiﬁed using CID fragmentation.
To widen the S. coelicolor glycoproteome characterization and to enable glycosyl-
ation site assignments to be made, enriched membrane glycoproteins isolated after
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FIG 2 Characterization of enriched glycoproteins by mass spectrometry. (A) CID spectrum of the glycopeptide SATAASPSAEASGEAGGTGK-9Hex from SCO4847,
isolated after 35 h of growth. Precursor m/z 1,055.7991; charge, 2; retention time (RT), 25.7 min; e-value, 0.0003. (B) S. coelicolor O-glycosylation site motif. (C)
Subcellular localization of S. coelicolor glycoproteins.
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43 h of growth were further analyzed by mass spectrometry using the complementary
fragmentation techniques, higher-energy collision dissociation (HCD) and electron
transfer dissociation (ETD). HCD fragmentation is a higher-energy form of CID available
on Orbitrap mass spectrometers and produces fragmentation patterns similar to those
of CID fragmentation (y- and b-type ions). In contrast, ETD fragmentation favors
cleavage of the peptide backbone (c- and z-type ions), leaving the glycan structure
intact, thereby facilitating glycosylation site localization (22). The combined data ac-
quisitions using the HCD and ETD fragmentation techniques resulted in the identiﬁca-
tion of thirty-six different S. coelicolor glycopeptides (Data Set S1). The spectrum with
the highest conﬁdence of a match for each glycopeptide is shown in Data Set S2. ETD
fragmentation allowed a further thirteen O-glycosylation sites to be assigned, nearly
double the number of assignments made after the CID and HCD experiments com-
bined. In total, O-glycosylation sites were assigned in approximately 30% of the
glycopeptides identiﬁed in this work. While no distinct consensus sequence was
identiﬁed, there was a high propensity for hydrophobic amino acids (e.g., Ala, Pro, and
Gly) near the glycosylation site (Fig. 2B). This feature is reminiscent of sequences
surrounding O-glycosylation sites in other Actinobacteria (14, 21, 23, 24). At least 30%
of the glycopeptides identiﬁed in this work were supported by multiple spectra. Hex,
Hex2, and Hex3 modiﬁcations were all detected, as expected. Searches for Hex4 and
Hex5 modiﬁcations revealed some hits; however, upon manual inspection of these
spectra it was determined that these were peptides with multiple sites modiﬁed with
Hex, Hex2, and Hex3.
In total, thirty-seven new S. coelicolor glycoproteins were identiﬁed (Table 1).
Additionally, the data acquired using ETD fragmentation enabled the further charac-
terization of the previously identiﬁed S. coelicolor glycoprotein PstS (SCO4142) (15) by
the assignment of two glycosylation sites (residue underlined) in glycopeptides
N-DGIKTVDVK-C and N-QTPGAISYFELSYAKDGIK-C (Data Set S1). Indeed, PstS is one of
the most heavily glycosylated proteins identiﬁed in this work, with at least three further
glycosylation sites that could not be deﬁned here (Fig. S3). Two of these glycopeptides
overlapped the synthetic peptides that were shown previously to be glycosylated in a
cell-free assay (15).
Database searches were carried out in order to classify the glycoproteins as either
lipoproteins, membrane proteins, or secreted proteins. Proteins were functionally
annotated using the Streptomyces genome database (StrepDB; http://strepdb
.streptomyces.org.uk/) and the Conserved Domain Database (CDD) (https://www.ncbi
.nlm.nih.gov/Structure/cdd/wrpsb.cgi) (25). In some cases, the literature was contradic-
tory to the results observed after the database searches. For example, SCO7218 is
annotated as a putative iron transport lipoprotein in the StrepDB. However, the LipoP
1.0 server did not predict a lipoprotein signal peptide (SpII) in this protein. SCO7218 is
upstream of an ABC transporter (SCO7216/SCO7217), which is consistent with the
known genome architecture of solute binding lipoproteins in S. coelicolor (26). In these
cases, the literature searches were considered to be more reliable in assigning a
category to the proteins.
Protein O-glycosylation by Pmt was shown to be coupled to protein secretion via
the Sec pathway in M. tuberculosis, suggesting that protein O-mannosylation should
only affect extracellular proteins (16). Consistent with this precedent, more than a third
of the newly identiﬁed S. coelicolor glycoproteins in this study were predicted lipopro-
teins and other secreted proteins (Fig. 2C). The lipoproteins included SCO3357 (CseA),
which is proposed to dampen the cell envelope stress response by the two-component
sensor regulators CseB and CseC, which activate the expression of the SigE-encoding
gene sco3356 (27, 28). In addition the putative lipoprotein, SCO4905 (AfsQ3) was also
glycosylated and is also proposed to be a modulator of a two-component sensor
regulator, AfsQ1/AfsQ2 (27). Many of the glycolipoproteins are, or are predicted to be,
substrate binding proteins that interact with ABC transporters (SCO0472, SCO5776,
SCO7218, SCO4885, and SCO4142). Nearly 50% of the glycoproteins identiﬁed in this
study are putative membrane proteins with predicted functions, including transport
Streptomyces coelicolor Membrane Glycoproteome ®
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(SCO4141 and SCO5818) and serine/threonine kinases (SCO3848), as well as many
proteins of unknown function (SCO2963, SCO3891, SCO4130, SCO4548, SCO4968,
SCO5204, and SCO5751). Additionally, ﬁve of the glycoproteins identiﬁed here had no
predicted transmembrane domains or secretory signals. Three of these, SCO5736,
SCO4307, and SCO5115, are very likely to be intracellular proteins; SCO5736 is a
predicted S15 ribosomal subunit, SCO4307 is an N-acetylmuramic acid (MurNAc)-6-
phosphate etherase (MurQ), an enzyme that acts intracellularly to recycle peptidogly-
can MurNAc (29), and SCO5115 (BldKD) is a predicted intracellular ATPase subunit for
an oligopeptide uptake system (30). Clearly, as these three proteins go against the
precedent that Pmt glycosylates only extracellular proteins, further investigations are
required to validate this observation.
Nearly 25% of the glycoproteins identiﬁed here are predicted to be TAT-targeted
proteins. The TAT protein transport system functions to secrete folded proteins across
the cytoplasmic membrane and to insert some integral membrane proteins into the
membrane (31). The pathway is well characterized in S. coelicolor, and it is known to
TABLE 1 S. coelicolor glycoproteins identiﬁed in this work
Protein Function TMHMM no.a SignalP 4.1b TatP 1.0c LipoP 1.0d Classification
SCO0472 Putative secreted protein Y; 0.548 Y; 0.381 SpII; 22.2623 Lipoprotein
SCO0996 Putative metal-binding lipoprotein Y; 0.526 N SpI; 11.5964 Lipoprotein
SCO1714 Putative secreted protein 1 Y; 0.498 N SpII; 12.878 Lipoprotein
SCO2838 Putative secreted endoglucanase Y; 0.639 Y; 0.377 SpII; 32.6736 Lipoprotein
SCO3357 Hypothetical protein N Y; 0.492 SpII; 17.3077 Lipoprotein
SCO4142 PstS, substrate binding domain of ABC-type phosphate
transporter
Y; 0.595 N SpII; 26.7983 Lipoprotein
SCO4739 Putative lipoprotein Y; 0.579 N SpII; 20.7928 Lipoprotein
SCO4885 Putative nucleoside-binding lipoprotein N N SpII; 23.8395 Lipoprotein
SCO4905 Putative lipoprotein Y; 0.574 N SpII; 13.7291 Lipoprotein
SCO4934 Putative L,D-transpeptidase Y; 0.571 Y; 0.483 SpII; 24.1553 Lipoprotein
SCO5646 Putative thiamine-binding lipoprotein N Y; 0.468 SpII; 13.5061 Lipoprotein
SCO7218 Putative iron transport lipoprotein Y; 0.632 N SpI; 14.1761 Lipoprotein
SCO2096 Transglutaminase/protease-like membrane protein 6 Y; 0.529 N SpII; 8.2333 Membrane
SCO2035 Putative disulﬁde oxidoreductase 1 N N N Membrane
SCO2156 Putative cytochrome c oxidase subunit II 3 N N N Membrane
SCO2963 Putative membrane protein 1 N N N Membrane
SCO3044 Putative cell envelope-associated transcriptional attenuator
LytR-CpsA-Psr
1 N N N Membrane
SCO3046 Putative cell envelope-associated transcriptional attenuator
LytR-CpsA-Psr
1 N N N Membrane
SCO3184 Putative penicillin acylase 1 N Y; 0.366 N Membrane
SCO3848 Putative serine/threonine protein kinase 1 N N N Membrane
SCO3891 Putative membrane protein 1 N N N Membrane
SCO4013 Putative secreted penicillin-binding protein FtsI 1 N N N Membrane
SCO4130 Putative integral membrane protein 1 N N N Membrane
SCO4141 Phosphate ABC transport system permease protein 5 N N N Membrane
SCO4256 Putative hydrolytic protein 1 N N N Membrane
SCO4548 Putative integral membrane protein 3 N Y; 0.479 N Membrane
SCO4968 Putative membrane protein 1 N N N Membrane
SCO5204 Integral membrane protein 7 N N N Membrane
SCO5751 Putative membrane protein 1 N N N Membrane
SCO5818 Putative ABC-type Na transport system 5 N N N Membrane
SCO3540 Proteinase (putative secreted protein) 1 Y; 0.627 Y; 0.700 SpI; 18.2099 Secreted
SCO4847 DacC, putative D-alanyl-D-alanine carboxypeptidase 1 Y; 0.711 Y; 0.427 SpI; 27.3476 Secreted
SCO5776 Glutamate binding protein Y; 0.618 N SpI; 21.8509 Secreted
SCO3353 Hypothetical protein N N N Other
SCO4307 MurQ, N-acetylmuramic acid-6-phosphate etherase N N N Other
SCO5115 BldKD, putative ABC transporter intracellular ATPase subunit N N N Other
SCO5736 30S ribosomal protein S15 N N N Other
SCO6558 Putative oxidoreductase N N N Other
aThe number of transmembrane helices predicted by the TMHMM 2.0 server (http://www.cbs.dtu.dk/services/TMHMM/).
bSignalP 4.1 software predicts the presence of a signal peptide (http://www.cbs.dtu.dk/services/SignalP/). d-score is a score used to discriminate signal peptides from
non-signal peptides. Scores of 0.450 indicate a signal peptide. Y, yes; N, no.
cTatP 1.0 predicts the presence of twin arginine (TAT) signal peptides. d-score of 0.36 predicts the presence of a TAT pathway signal.
dLipoP 1.0 software produces predictions of lipoproteins (http://www.cbs.dtu.dk/services/LipoP/). SpI denotes SEC signal peptide; SpII denotes lipoprotein.
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translocate large numbers of lipoproteins (26, 32). SCO4934, a predicted L,D-
transpeptidase and glycoprotein identiﬁed in this study, was experimentally veriﬁed as
a TAT substrate by Thompson et al. (26) after it was shown to be absent from S.
coelicolor tatC strains. In mycobacteria, the fact that protein O-glycosylation was
shown to be coupled to protein translocation via the Sec pathway suggests that protein
O-glycosylation occurs on unfolded proteins (16). While protein O-mannosylation in
eukaryotes is conventionally thought to be coupled to protein translocation into the
endoplasmic reticulum (ER), Pmt-mediated glycosylation of misfolded proteins after
they have been translocated into the ER has been demonstrated (33). The translocation
of glycoproteins via the TAT pathway in S. coelicolor suggests that glycosylation is also
possible on folded proteins. Although Pmt has not been shown deﬁnitively to be the
enzyme that glycosylates proteins secreted through the TAT pathway, one could
envisage that the glycosylation occurs on surface-exposed regions of the protein or in
ﬂexible loops that link secondary structure elements.
Glycoproteins with functions in cell wall biogenesis. Upon characterizing the
membrane glycoproteome in S. coelicolor, we were particularly interested in proteins
that could help to explain the antibiotic hypersensitivity phenotypes observed previ-
ously in the pmt and ppm1 mutant S. coelicolor strains (6). It was hypothesized that the
S. coelicolor glycoproteome could contain proteins that are important in cell wall
biosynthesis or for maintaining membrane integrity. In this study, at least seven
glycoproteins have been identiﬁed that have predicted functions in the cell wall
(SCO4934, SCO4847, SCO3044, SCO3046, SCO3184, SCO4013, and SCO4307). SCO4847,
for example, is a putative D-Ala-D-Ala carboxypeptidase and low-molecular-weight
penicillin-binding protein. These proteins are thought to catalyze the hydrolysis of the
terminal D-alanine from the peptidoglycan stem peptide (34). SCO4013 is another
predicted penicillin binding protein, while SCO4934 is a predicted L,D-transpeptidase.
L,D-Transpeptidases catalyze an alternative type of peptidoglycan cross-linking between
the third-position amino acids of tetrapeptide stems, termed 3¡3 cross-linking. L,D-
transpeptidases have been identiﬁed in M. tuberculosis and were shown to be impor-
tant for maintaining cell shape, virulence, and resistance to -lactam antibiotics (35).
SCO3044 and SCO3046 both belong to the LytR-CpsA-Psr (LCP) family of proteins that
were ﬁrst shown to catalyze the ligation of wall teichoic acids (WTA) to the MurNAc
units of peptidoglycan in Bacillus subtilis (36). Other studies have demonstrated that
LCP proteins are required to attach the capsular polysaccharide to peptidoglycan in
both Staphylococcus aureus and Streptococcus pneumoniae (37, 38). Recently, however,
an LCP protein in M. tuberculosis (Lcp1) was shown to be required for cell viability and
to attach arabinogalactan to peptidoglycan in a cell-free assay (39).
To investigate the putative roles of glycoproteins SCO4847 and SCO4934 in cell wall
biosynthesis, sco4847 and sco4934 were disrupted in S. coelicolor by allelic exchange
with cosmids containing Tn5062 in the gene of interest. The susceptibilities of the
sco4847 (TK006) and sco4934 (TK008) mutant strains to a range of antibiotics were
measured (Fig. 3). Both sco4847 (TK006) and sco4934 (TK008) mutants were signiﬁcantly
more susceptible to the -lactam antibiotics imipenem, meropenem, ampicillin, and
penicillin than the S. coelicolor parent strain J1929 (Fig. 3A and B). Additionally, sco4847
(TK006) mutants displayed a slight increase in sensitivity to vancomycin compared to
that of J1929 (Fig. 3A). Both mutants were more sensitive to the antibiotics than DT1025
(pmtmutant), suggesting that the nonglycosylated SCO4847 and SCO4934 isoforms still
have some activity in DT1025. The increased antibiotic susceptibility was partially
complemented upon the reintroduction of the wild-type copies of sco4847 and
sco4934, respectively. Neither of the mutants displayed any change in susceptibility to
rifampin, bacitracin, or teicoplanin (Data Set S3), suggesting that the mutants were only
affected by antibiotics that targeted peptidoglycan cross-linking. To further investigate
the roles of SCO4847 and SCO4934 in cell wall biosynthesis, the susceptibility of the
sco4847 (TK006) and sco4934 (TK008) mutants to lysozyme was tested. The sco4847
(TK006) mutant was more sensitive to lysozyme treatment than J1929 and DT1025 (pmt
Streptomyces coelicolor Membrane Glycoproteome ®
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mutant), and a wild-type level of lysozyme sensitivity was restored in the comple-
mented strain (TK013) (Fig. 3C). No change in lysozyme sensitivity was observed in the
sco4934 (TK008) mutant (Fig. S4). Neither of the mutants displayed any changes in
colony morphology, sporulation, or C31c25 phage sensitivity (data not shown). The
increase in susceptibility to cell wall-targeting antibiotics in the glycoprotein-deﬁcient
mutants suggests that both proteins are required for maintaining normal cell wall
integrity in S. coelicolor. The lack of sensitivity to lysozyme observed in the sco4934
mutant may be due to the compensatory actions of other L,D-transpeptidases in the cell.
A BLAST search of the SCO4934 protein sequence against the StrepDB revealed at least
three other putative L,D-transpeptidases in the S. coelicolor genome (SCO3194,
SCO5458, and SCO5457). The increased lysozyme susceptibility observed in the sco4847
(TK006) mutant suggests that SCO4847 has a very speciﬁc role in cell wall biosynthesis
of S. coelicolor or is required during a speciﬁc growth stage.
Conclusions. In this study, we have combined biochemical and MS-based ap-
proaches to isolate and characterize the membrane O-glycoproteome in S. coelicolor.
Collectively we have identiﬁed thirty-seven new S. coelicolor glycoproteins and further
characterized the previously identiﬁed glycoprotein, PstS (15). As in M. tuberculosis (12,
14), S. coelicolor glycosylates a large number of proteins with a wide range of biological
functions, including solute binding, polysaccharide hydrolases, ABC transporters, and
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FIG 3 Antibiotic sensitivities of glycoprotein-deﬁcient mutants. (A and B) Diameters of growth inhibition zones from disc diffusion assays
for the S. coelicolor glycoprotein-deﬁcient mutants TK006 (sco4847::Tn5062) (A) and TK008 (sco4934::Tn5062) (B) and respective comple-
ment strains TK013 (sco4847::Tn5062, pTAK30) and TK010 (sco4934::Tn5062, pTAK32) against the parent strain J1929 and the glycosylation-
deﬁcient strain DT1025 (pmt mutant). Means from three biological replicates are shown, except for TK006, where the means from two
biological replicates and three technical replicates are shown. Error bars indicate standard errors of the means. An asterisk indicates a P
value of 0.05, i.e., that the difference between the glycoprotein-deﬁcient mutant and the parent strain J1929 has occurred by chance.
Only a selection of antibiotic concentrations (vancomycin, 40 g; imipenem, 4 g; meropenem, 4 g; penicillin, 100 g; ampicillin,
200 g) are shown here; the full set is in Data Set S3. (C) Lysozyme sensitivity of TK006 (sco4847::Tn5062) and complement strain TK013
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representative of two biological replicates and two technical replicates.
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cell wall biosynthesis. Glycosylation sites were found to be modiﬁed with up to three
hexose residues, which is consistent with what has been seen previously in other
Actinobacteria (10, 13, 14). The identiﬁcation of glycoproteins with putative roles in cell
wall biogenesis supports our hypothesis that glycoproteins in S. coelicolor are required
for maintaining cell wall integrity. Upon further investigation of two of these glyco-
proteins, a putative D-Ala-D-Ala carboxypeptidase (SCO4847) and an L,D-transpeptidase
(SCO4934), through the generation of null mutants we were able to reproduce the
antibiotic susceptibility phenotype observed previously in the S. coelicolor pmtmutants
(6). Additionally, the sco4847 mutants displayed an increased susceptibility to lysozyme
treatment. These ﬁndings strongly suggest that both glycoproteins are required for
maintaining cell wall integrity and that glycosylation affects enzyme function.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. Bacterial strains, plasmids, cosmids, and
primers used in this work are listed in Table S1 in the supplemental material. Escherichia coli strains were
grown in LB or on LB agar. Streptomyces coelicolor A3 (2) strains were maintained on solid soya ﬂour
mannitol (SFM) medium, from which spores were harvested and kept frozen in 20% glycerol at 38°C
(40). For the preparation of mycelium from liquid cultures, pregerminated spores (40) were inoculated
into F134 medium (19) to an optical density at 450 nm (OD450) of 0.03 to 0.05 and grown at 30°C with
shaking (180 rpm) for up to 60 h. E. coli DH5 was used as a cloning host, and plasmids/cosmids were
introduced into S. coelicolor by conjugation from the donor E. coli strain ET12567(pUZ8002) (40, 41).
Apramycin (cosmids) or hygromycin (complementation plasmids) was used to select for exconjugates,
and nalidixic acid was used to prevent growth of the E. coli donors. S. coelicolor strains containing a
Tn5062 insertion in the desired gene in the chromosome were obtained by screening exconjugants for
those that had undergone double crossovers with the incoming cosmids and were apramycin resistant
and kanamycin sensitive. Tn5062 insertion mutants and complemented strains were validated by PCR
and Southern blotting.
Construction of the complementation plasmids. For the construction of the sco4934 complemen-
tation plasmid pTAK32, the sco4934 coding sequence was ampliﬁed by PCR from S. coelicolor J1929
genomic DNA using primers TK101 and TK102 (Table S1) and cloned into NdeI-digested pIJ10257. For the
construction of the sco4847 complementation plasmid pTAK30, the sco4847 coding sequence could not
be ampliﬁed by PCR from S. coelicolor J1929 genomic DNA, as it contained several sequence repeats. To
simplify the template for PCR, the cosmid St5G8 was restricted with BamHI and separated by agarose gel
electrophoresis, and a 2,270-bp product containing the sco4847 coding sequence was excised and gel
extracted. The puriﬁed DNA was used as a template for the ampliﬁcation of sco4847 by PCR with primers
TK97 and TK98 (Table S1). The resulting PCR product was cloned into NdeI-digested pIJ10257. All
plasmids were validated by DNA sequencing.
Antibiotic disc diffusion assays. Antibiotic disc diffusion assays were performed as described
previously (6). Brieﬂy, Difco nutrient agar plates were overlaid with soft nutrient agar (2.5 ml) containing
107 S. coelicolor spores. Sterile ﬁlter discs (5-mm width) were placed on the surface of the soft agar, and
5 l of antibiotic stock solution was allowed to absorb to the disc. Plates were incubated at 30°C for
2 days and zones of inhibition (measured in millimeters) were recorded.
Lysozyme sensitivity assays. Lysozyme sensitivity assays were performed by plating 5 l of a
dilution series of S. coelicolor spores (108 to 104 spores/ml in double-distilled H2O) onto Difco nutrient
agar plates with and without lysozyme (0.25 mg/ml) and incubated at 30°C for 60 h.
Preparation of S. coelicolor membrane proteins. S. coelicolor membrane proteins were isolated as
previously described (15). Brieﬂy, the mycelium from liquid cultures was harvested by centrifugation (5min,
3,500 g, 4°C) and washed in 20mM Tris-HCl buffer (pH 8, 4°C). Mycelial pellets were resuspended in twice
the pellet volume of lysis buffer at 4°C (20mM Tris-HCl, pH 8, 4mMMgCl2, protease inhibitor tablet according
to volume [Roche] and 1 unit mlˉ1 Benzonase [Sigma]). The mycelium was lysed using a manual French press
(Thermo Fisher Scientiﬁc) at 25,000 lb/in2 kPsi. Cell debris was removed by centrifugation (30min, 5,525  g,
followed by 30min at 12,000 to 15,000  g, 4°C). Membranes in the supernatant were pelleted by
ultracentrifugation (1 h, 100,000  g, 4°C). Membrane pellets were solubilized overnight on ice in 1% (wt/vol)
dodecyl--D-maltoside (Sigma) in 20mM Tris-HCl buffer (pH 8).
SDS-PAGE and lectin Western blotting. Protein concentrations were determined using the Pierce
Coomassie (Bradford) assay kit (Thermo Fisher Scientiﬁc). Proteins were prepared by boiling in 1
RunBlue LDS sample buffer (Expedeon) with -mercaptoethanol (5% [vol/vol]) and separated in RunBlue
4 to 12% SDS protein gels (Expedeon). For protein staining, gels were soaked in InstantBlue protein stain
(Expedeon) per the manufacturer’s instructions. For glycoprotein detection, proteins were transferred to
PVDF membranes by semidry Western transfer (42). Nonspeciﬁc binding to the membranes was blocked
by incubation in TBS (50 mM Tris-HCl, 150 mM NaCl, pH 7.5) plus 2% (vol/vol) Tween 20 for 30 min, before
washing the membranes 2  5 min in TBS. Membranes were incubated for 2 h in TBS plus 0.05% (vol/vol)
Tween 20, 1 mM MgCl2, 1 mM MnCl2, and 1 mM CaCl2 with 5 g·ml
1 ConA-HRP conjugate (Sigma). For
the inhibition of glycoprotein binding, membranes were incubated for 2 h in TBS plus 0.05% (vol/vol)
Tween 20, 1 mM MgCl2, 1 mM MnCl2, and 1 mM CaCl2 with 5 g·mlˉ
1 ConA-HRP conjugate and 200 mM
methyl -D-glucopyranoside. The membranes were washed twice for 10 min each time in TBS plus 0.05%
(vol/vol) Tween 20 and once for 5 min in TBS. Chemiluminescent detection solution was prepared by
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adding 5 ml of 100 mM Tris-HCl, pH 8.5, buffer with 0.2 mM p-coumaric acid (Sigma) and 1.25 mM luminol
to 15 l of 3% (vol/vol) hydrogen peroxide solution. Under dark-room conditions, the membranes were
incubated in chemiluminescent detection solution for 1 min. After exposure to the blot, X-ray ﬁlm (GE
Healthcare Life Sciences) was incubated for 3 to 5 min in Developer solution (Kodak) and 3 min in Fixer
solution (Kodak).
Lectin affinity chromatography. Lectin afﬁnity chromatography was performed on the AKTA pure
chromatography system (GE Healthcare) using a column of agarose-bound ConA (Vector Laboratories).
Prior to sample loading, the column was washed in lectin buffer (20 mM Tris-HCl, pH 7.5, 400 mM NaCl,
5 mM MgCl2, 5 mM MnCl2, and 5 mM CaCl2) and then equilibrated in 5 column volumes (CV) of binding
buffer (20 mM Tris-HCl, pH 7.5, 0.4 M NaCl, and 0.1% [wt/vol] n-dodecyl -D-maltoside). Samples were
loaded onto the column at a ﬂow rate of 5 ml·minˉ1, the column was washed with 16 CV of binding
buffer, and glycoproteins were eluted in 4 CV of a 200 mM methyl -D-glucopyranoside solution.
Glycoprotein fractions were concentrated using Amicon ultracentrifugal ﬁlters (9-kDa molecular weight
cutoff; Merck) and stored in 50% (wt/vol) glycerol at 80°C.
Glycoproteomics. For detailed glycoproteomics methods, please see Text S1 in the supplemental
material. Glycoproteins were in-gel digested with trypsin before LC-MS/MS acquisition over 180 min
using multiple fragmentation strategies. CID fragmentation acquisitions were performed using a Waters
nanoAcquity ultraperformance liquid chromatograph interfaced to a Bruker maXis HD mass spectrom-
eter as previously described (43). HCD, ETD, and mixed fragmentation acquisitions were performed using
a Thermo UltiMate 3000 RSLCnano high-performance liquid chromatograph and Orbitrap Fusion hybrid
mass spectrometer. Four MS/MS strategies were employed: ETD spectra acquired in the linear ion trap
(ETD_IT), ETD spectra acquired in the Orbitrap (ETD_OT), HCD spectra acquired in the linear ion trap
(HCD_IT), and HCD spectra acquired in the linear ion trap with ETD spectra acquired in the Orbitrap
(HCD/ETD IC). Resulting tandem mass spectral data were searched against the Streptomyces coelicolor
subset of the NCBI database using Mascot. Search criteria were the following: enzyme, trypsin; ﬁxed
modiﬁcations, carbamidomethyl (C); variable modiﬁcations, oxidation (M), deamidated (NQ), and Hex(1–5)
(ST). Mass tolerance and fragmentation ion types were adjusted to match acquisition dependencies (see
the supplemental material). Peptide spectral matches were ﬁltered to expect scores of 0.05. All
glycopeptide spectra with MASCOT expect scores of 0.05 or lower were manually validated. For
glycopeptide spectra generated by CID and HCD fragmentation, glycosylation sites were only assigned
in cases where only a single glycosylated residue was possible within the glycopeptide. For the site
localizations of glycopeptides identiﬁed in the ETD_IT and ETD_OT acquisitions, an MD score cutoff of 10
was applied. In matches where the MD score was greater than 10, the spectra were manually validated
to conﬁrm the site localization.
Data availability. All proteomics data are available through MassIVE as data set MSV000083115.
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